Results 201 to 210 of about 8,449,566 (292)

Cross-Border Circulation and Molecular Surveillance of HIV-1 in the Azov and Donbas Regions: A Study of Genetic Diversity and Drug Resistance. [PDF]

Viruses
Antonova A, Vinokurov A, Kustova D, Pochtovyi A, Ogarkova D, Adgamov R, Kuznetsova A, Tsyganova E, Kulikova I, Plutnitskii A, Gushchin V, Gintsburg A, Logunov D, Mazus A.   +13 more
europepmc   +1 more source

Gut Microbiota Alterations in People Living With HIV: Dysbiosis, Immune Dysfunction and Therapeutic Perspectives. [PDF]

Rev Med Virol
El Mheddeb S, El Kettani A, Bousfiha AA, Ezzikouri S, Ouladlahsen A.   +4 more
europepmc   +1 more source

Real-World Experience With Lenacapavir and/or Fostemsavir as Emerging Therapies for the Management of Multidrug-Resistant HIV-1 in Southeastern France. [PDF]

J Med Virol
Boujamline S, Boschi C, Bes-Barlandier H, Tomei C, Menard A, Mokhtari S, Ravaux I, Belkhir Y, Neant N, Solas C, Colson P, Million M.   +11 more
europepmc   +1 more source

Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve. [PDF]

Clin Infect Dis
Graber CJ, Landovitz RJ, Branch-Elliman W.   +2 more
europepmc   +1 more source

Review of Risk Factors and Factors Influencing Outcomes of Cryptococcal Meningitis in Persons Living with HIV. [PDF]

Infect Drug Resist
Rutakingirwa MK, Skipper CP, Meya DB.
europepmc   +1 more source

Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era.

Clinical Infectious Diseases, 2012
R. MacArthur, H. DuPont
semanticscholar   +1 more source

Similar Efficacy, Safety, and Immune Improvement Through 96 Weeks in Individuals With Limited HIV-1 Treatment Options Using Twice-Daily Dolutegravir- or Fostemsavir-based Regimens. [PDF]

Open Forum Infect Dis
Castagna A, Marcon I, Du F, Li B, Wang M, Clark A, Donovan C, Jones B, Prakash M.   +8 more
europepmc   +1 more source

Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV‐1 reservoirs: results from a multicentre randomized clinical study

HIV Medicine, 2012
J. P. Routy, C. Tremblay, J. B. Ángel, B. Trottier, D. Rouleau, J. Baril, M. Harris, S. Trottier, J. Singer, N. Chomont, R. Sekaly, M. R. Boulassel   +11 more
semanticscholar   +1 more source

Reversible HIV-Associated Nephropathy and Concomitant Encephalomyelopathy as the Initial Presentation of Advanced, Untreated HIV. [PDF]

Cureus
Ya Minn M, Umer MQ, Madu AC, Stacey H, Sujith A.   +4 more
europepmc   +1 more source

Pooled Multinomial Logistic Regression for Parametric G-computation in the Presence of Competing Events. [PDF]

Epidemiology
Neuroth LM, Swilley-Martinez ME, Zivich PN, Edwards JK, Edwards JK.   +4 more
europepmc   +1 more source